ArticleInternational journal of surgery case reports2026
A rare indolent neuroendocrine tumor of the left intrahepatic bile duct: a case report emphasizing early detection.
Article in International journal of surgery case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Neuroendocrine tumors (NETs) have traditionally been considered rare; however, an increasing incidence has been observed in recent years. Although often indolent, these tumors can exhibit malignant behavior. Our case of a left intrahepatic duct NET in a young woman highlights this rare presentation and underscores the need for heightened clinical awareness. Case Presentation: A 32-year-old woman presented with pruritus, jaundice, and mild elevations in liver enzymes. Imaging revealed a 40 × 33 mm mass in the vicinity of the left bile duct, in segment 4 of the liver. Octreotide scintigraphy confirmed the lesion as primary, and biopsy demonstrated a grade II well-differentiated NET. She underwent left hepatectomy with Roux-en-Y hepaticojejunostomy and lymphadenectomy. Postoperative recovery was uneventful except for mild atelectasis, which resolved with supportive care; she was discharged on postoperative day 8. Discussion: Primary intrahepatic bile duct NETs are extremely rare and may originate from biliary neuroendocrine cells or pluripotent stem cells. They often present with nonspecific symptoms such as jaundice or pruritus and can mimic cholangiocarcinoma. In this case, the tumor arose from the left intrahepatic bile duct without evidence of metastasis. Advanced imaging modalities, including magnetic resonance imaging, magnetic resonance cholangiopancreatography, and diffusion-weighted imaging, were crucial for diagnosis and surgical planning. Conclusion: Primary intrahepatic bile duct NETs are rare, present with nonspecific features, and require a multimodal diagnostic approach, with surgical resection offering favorable outcomes for localized, well-differentiated lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.